Essentials: Understanding & Treating Addiction | Dr. Anna Lembke

In this Huberman Lab Essentials episode, Dr. Anna Lembke, Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic, explores the neurobiology of addiction through the lens of dopamine signaling. She explains that dopamine is not simply a pleasure chemical but rather a critical neurotransmitter that regulates reward, motivation, and movement. Understanding how dopamine functions provides crucial insight into why addiction develops and persists across multiple forms including substances, alcohol, food, and behaviors like social media use. Dr. Lembke introduces the foundational concept of baseline dopamine, which varies significantly between individuals based on genetic factors and temperament. Some people naturally have lower baseline dopamine and are therefore more vulnerable to addiction as they seek external sources to boost their dopamine levels. This genetic predisposition helps explain why addiction runs in families and why not everyone exposed to the same substances or behaviors becomes addicted. The episode delves into how modern life with constant stimulation and limited boredom has created an epidemic of addictive behaviors. When we continuously seek pleasure through various stimuli, we set ourselves up for the pleasure-pain balance mechanism that drives addiction. Dr. Lembke explains that when dopamine is artificially elevated through addictive substances or behaviors, the brain compensates by reducing dopamine sensitivity and lowering baseline dopamine below normal levels. This creates a painful state that drives individuals to repeat the addictive behavior to escape the discomfort, establishing a vicious cycle. One of the key tools discussed is the 30-day abstinence protocol, which allows the dopamine system to reset and recalibrate by removing the addictive stimulus entirely. This period of withdrawal is neurologically uncomfortable but necessary for the nervous system to reestablish normal dopamine function. The conversation addresses relapse as a neurological phenomenon rather than a moral failure, emphasizing that relapse reflects reflexive behavior driven by dopamine dysregulation and learned associations with triggers. Understanding this neurobiological basis promotes empathy for those struggling with addiction. The episode explores how shame perpetuates addiction cycles, as individuals feel deep guilt about their behavior which further drives the need to escape through addictive practices. Dr. Lembke discusses emerging evidence for psychedelic-assisted therapy using compounds like psilocybin and MDMA in addiction treatment. These substances appear to promote neuroplasticity and reduce the shame that often maintains addictive patterns, offering new therapeutic avenues beyond traditional approaches. Finally, the episode addresses social media addiction as a contemporary behavioral addiction, suggesting that intentionality in how we engage with these platforms is essential for preventing dopamine dysregulation and maintaining psychological health.